NCT01186432View on ClinicalTrials.gov

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

April 30, 2014

Conditions

Age-Related Macular Degeneration

Interventions

DRUG

PDS 1.0

Trial Locations (1)

Unknown

Riga

Sponsors

Lead Sponsor

Forsight Vision4

All Listed Sponsors

lead

Forsight Vision4

INDUSTRY